- Everlab, known for its AI-powered preventive health model, plans to scale operations across Australia and internationally after securing $10M.
- The funding will support infrastructure, international rollout, and further development of its AI platform that aims to transform chronic disease prevention.
Melbourne-based AI healthtech company Everlab has raised $10 million in startup funding to continue on its mission to transform preventive healthcare using advanced technology and data-driven care.
Global growth equity firm Left Lane Capital led the round. It will drive the international expansion of Everlab, develop its in-house artificial intelligence (AI) healthtech platform, and scale clinic operations in both Australia and overseas.
Everlab was established by CEO Marc Hermann to meet the growing burden of chronic disease, which is responsible for over 70% of all deaths globally, by transforming the approach of healthcare from reactive treatment to proactive prevention.
“Our goal is to make world-class preventive care accessible to everyone,” said Marc Hermann, founder and CEO of Everlab. “By combining the analytical power of AI with expert clinicians, we deliver smarter, earlier care that can truly change lives”.
Whole-body MRIs, DEXA scans, ECGs, continuous glucose monitoring, and sophisticated blood tests are integrated with one-on-one digital-first consultations and longitudinal health records as part of the firm's tiered membership offering.
Members are given personalised prevention plans and ongoing support. There is a "50-year personalised health roadmap" as part of the flagship Protocol membership.
Its patent-pending platform, which applies sophisticated AI agents to collect, interpret, and analyse an enormous amount of health information, automate clinical summaries, and detect early warning signs, forms the backbone of its service.
The technology seeks to liberate clinicians from administrative tasks so that they can carry out earlier, more accurate interventions at scale.
With tens of thousands on its waitlist and clinics in most Australian capital cities, Everlab is ready to accelerate growth, with a goal of 20x growth this year.
The new capital will go towards growing the clinical and engineering team, scaling infrastructure, and bringing preventive healthcare to a wider population.
Edited by Annette George
